134 related articles for article (PubMed ID: 37419729)
21. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study.
Ciccone G; Mirabelli D; Levis A; Gavarotti P; Rege-Cambrin G; Davico L; Vineis P
Cancer Genet Cytogenet; 1993 Jul; 68(2):135-9. PubMed ID: 8353805
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
23. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
[TBL] [Abstract][Full Text] [Related]
24. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
25. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
[TBL] [Abstract][Full Text] [Related]
26. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
27. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
28. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
Kaplan HG; Malmgren JA; Atwood MK
BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
[TBL] [Abstract][Full Text] [Related]
29. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Bloomfield CD; Archer KJ; Mrózek K; Lillington DM; Kaneko Y; Head DR; Dal Cin P; Raimondi SC
Genes Chromosomes Cancer; 2002 Apr; 33(4):362-78. PubMed ID: 11921271
[TBL] [Abstract][Full Text] [Related]
30. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
Gruschkus SK; Lairson D; Dunn JK; Risser J; Du XL
Cancer; 2010 Nov; 116(22):5279-89. PubMed ID: 20665502
[TBL] [Abstract][Full Text] [Related]
31. Benzene and lymphohematopoietic malignancies in China.
Hayes RB; Yin S; Rothman N; Dosemeci M; Li G; Travis LT; Smith MT; Linet MS
J Toxicol Environ Health A; 2000 Nov; 61(5-6):419-32. PubMed ID: 11086948
[TBL] [Abstract][Full Text] [Related]
32. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.
Radivoyevitch T; Dean RM; Shaw BE; Brazauskas R; Tecca HR; Molenaar RJ; Battiwalla M; Savani BN; Flowers MED; Cooke KR; Hamilton BK; Kalaycio M; Maciejewski JP; Ahmed I; Akpek G; Bajel A; Buchbinder D; Cahn JY; D'Souza A; Daly A; DeFilipp Z; Ganguly S; Hamadani M; Hayashi RJ; Hematti P; Inamoto Y; Khera N; Kindwall-Keller T; Landau H; Lazarus H; Majhail NS; Marks DI; Olsson RF; Seo S; Steinberg A; William BM; Wirk B; Yared JA; Aljurf M; Abidi MH; Allewelt H; Beitinjaneh A; Cook R; Cornell RF; Fay JW; Hale G; Chakrabarty JH; Jodele S; Kasow KA; Mahindra A; Malone AK; Popat U; Rizzo JD; Schouten HC; Warwick AB; Wood WA; Sekeres MA; Litzow MR; Gale RP; Hashmi SK
Leuk Res; 2018 Nov; 74():130-136. PubMed ID: 30055822
[TBL] [Abstract][Full Text] [Related]
33. Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers.
Rushton L; Schnatter AR; Tang G; Glass DC
Br J Cancer; 2014 Feb; 110(3):783-7. PubMed ID: 24357793
[TBL] [Abstract][Full Text] [Related]
34. Benzene-contaminated toluene and acute myeloid leukemia: a case series and review of literature.
Peckham T; Kopstein M; Klein J; Dahlgren J
Toxicol Ind Health; 2014 Feb; 30(1):73-81. PubMed ID: 22740617
[TBL] [Abstract][Full Text] [Related]
35. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.
Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S;
Int J Cancer; 2018 Mar; 142(6):1130-1138. PubMed ID: 29076523
[TBL] [Abstract][Full Text] [Related]
36. Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials.
Nitecki R; Melamed A; Gockley AA; Floyd J; Krause KJ; Coleman RL; Matulonis UA; Giordano SH; Lu KH; Rauh-Hain JA
Gynecol Oncol; 2021 Jun; 161(3):653-659. PubMed ID: 33736856
[TBL] [Abstract][Full Text] [Related]
37. [A case-control study of risk factors for myelodysplastic syndromes].
Lv L; Lin GW; Wang XQ; Bao LM; Zou HJ
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Dec; 25(12):705-9. PubMed ID: 18230297
[TBL] [Abstract][Full Text] [Related]
38. Occupational exposure to benzene in South Korea.
Kang SK; Lee MY; Kim TK; Lee JO; Ahn YS
Chem Biol Interact; 2005 May; 153-154():65-74. PubMed ID: 15935801
[TBL] [Abstract][Full Text] [Related]
39. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience.
Smith RE
Clin Breast Cancer; 2003 Oct; 4(4):273-9. PubMed ID: 14651772
[TBL] [Abstract][Full Text] [Related]
40. A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.
Quintás-Cardama A; Daver N; Kim H; Dinardo C; Jabbour E; Kadia T; Borthakur G; Pierce S; Shan J; Cardenas-Turanzas M; Cortes J; Ravandi F; Wierda W; Estrov Z; Faderl S; Wei Y; Kantarjian H; Garcia-Manero G
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):401-10. PubMed ID: 24875590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
